<DOC>
	<DOC>NCT02382783</DOC>
	<brief_summary>The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).</brief_summary>
	<brief_title>Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)</brief_title>
	<detailed_description>This project is aimed at developing an improved multilevel care process model for the management of rheumatoid arthritis (RA) disease activity by implementing systematic self-monitoring of flare experiences by RA patients, combined with continuous patient-tailored adjustments of treatment modalities by a coordinated team of rheumatology health care providers (RHCPs).</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Inclusion Criteria Patient must be â‰¥ 18 years of age. Patient must have been seen by a rheumatology health care provider at least two times within the last 18 months at Mayo Clinic Rochester. Patient must have rheumatoid arthritis (RA) according to the 2010 ACR/EULAR classification criteria. Patient must have the ability to understand and the willingness to sign a written informed consent document. Patient must be willing to return to Mayo Clinic Rochester for followup appointments and fill out questionnaires as outlined in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Disease Activity</keyword>
	<keyword>Flare</keyword>
	<keyword>Management of Flares</keyword>
	<keyword>Pfizer</keyword>
</DOC>